Overview

JAAD Journal Articles Review

• Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis - Vivian Li, MD
• Efficacy, safety, and recurrence in seborrheic dermatitis: A dose-dependent analysis of oral isotretinoin (10 mg vs 20 mg) - Akhil Abraham, MD
• Efficacy, safety, and B-cell depletion capacity of 3 rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus - Carly Grant, MD
• Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3 - Paayal Vora, MD

Accreditation

HealthPartners is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

HealthPartners Office of Continuing Medical Education designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives

Regularly attending this series will allow participants to be able to:

• Apply best practices and current guidelines in treating dermatological conditions  
• Practice the art of reading an article and reviewing its merits
• Engage in discussion of how the article can lead to changes in medical practice